These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
883 related items for PubMed ID: 11222501
1. The non-classical MHC class I molecule Qa-1(b) inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes. Lohwasser S, Kubota A, Salcedo M, Lian RH, Takei F. Int Immunol; 2001 Mar; 13(3):321-7. PubMed ID: 11222501 [Abstract] [Full Text] [Related]
2. The nonclassical MHC class I molecule Qa-1 forms unstable peptide complexes. Kambayashi T, Kraft-Leavy JR, Dauner JG, Sullivan BA, Laur O, Jensen PE. J Immunol; 2004 Feb 01; 172(3):1661-9. PubMed ID: 14734748 [Abstract] [Full Text] [Related]
3. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. Mingari MC, Ponte M, Bertone S, Schiavetti F, Vitale C, Bellomo R, Moretta A, Moretta L. Proc Natl Acad Sci U S A; 1998 Feb 03; 95(3):1172-7. PubMed ID: 9448304 [Abstract] [Full Text] [Related]
4. Direct binding of purified HLA class I antigens by soluble NKG2/CD94 C-type lectins from natural killer cells. Ding Y, Sumitran S, Holgersson J. Scand J Immunol; 1999 May 03; 49(5):459-65. PubMed ID: 10320637 [Abstract] [Full Text] [Related]
5. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma. Sheu BC, Chiou SH, Lin HH, Chow SN, Huang SC, Ho HN, Hsu SM. Cancer Res; 2005 Apr 01; 65(7):2921-9. PubMed ID: 15805295 [Abstract] [Full Text] [Related]
6. Mouse CD94 participates in Qa-1-mediated self recognition by NK cells and delivers inhibitory signals independent of Ly-49. Toyama-Sorimachi N, Taguchi Y, Yagita H, Kitamura F, Kawasaki A, Koyasu S, Karasuyama H. J Immunol; 2001 Mar 15; 166(6):3771-9. PubMed ID: 11238619 [Abstract] [Full Text] [Related]
7. CD94/NKG2 expression does not inhibit cytotoxic function of lymphocytic choriomeningitis virus-specific CD8+ T cells. Miller JD, Peters M, Oran AE, Beresford GW, Harrington L, Boss JM, Altman JD. J Immunol; 2002 Jul 15; 169(2):693-701. PubMed ID: 12097371 [Abstract] [Full Text] [Related]
8. The specific regulation of immune responses by CD8+ T cells restricted by the MHC class Ib molecule, Qa-1. Jiang H, Chess L. Annu Rev Immunol; 2000 Jul 15; 18():185-216. PubMed ID: 10837057 [Abstract] [Full Text] [Related]
9. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Braud VM, Allan DS, O'Callaghan CA, Söderström K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ. Nature; 1998 Feb 19; 391(6669):795-9. PubMed ID: 9486650 [Abstract] [Full Text] [Related]
10. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). Vance RE, Kraft JR, Altman JD, Jensen PE, Raulet DH. J Exp Med; 1998 Nov 16; 188(10):1841-8. PubMed ID: 9815261 [Abstract] [Full Text] [Related]
11. Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro. Lian RH, Maeda M, Lohwasser S, Delcommenne M, Nakano T, Vance RE, Raulet DH, Takei F. J Immunol; 2002 May 15; 168(10):4980-7. PubMed ID: 11994449 [Abstract] [Full Text] [Related]
12. Structure of the murine CD94-NKG2A receptor in complex with Qa-1b presenting an MHC-I leader peptide. MacLachlan BJ, Sullivan LC, Brooks AG, Rossjohn J, Vivian JP. FEBS J; 2024 Apr 15; 291(7):1530-1544. PubMed ID: 38158698 [Abstract] [Full Text] [Related]
13. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells. Brooks AG, Borrego F, Posch PE, Patamawenu A, Scorzelli CJ, Ulbrecht M, Weiss EH, Coligan JE. J Immunol; 1999 Jan 01; 162(1):305-13. PubMed ID: 9886400 [Abstract] [Full Text] [Related]
14. Viral and bacterial infections induce expression of multiple NK cell receptors in responding CD8(+) T cells. McMahon CW, Zajac AJ, Jamieson AM, Corral L, Hammer GE, Ahmed R, Raulet DH. J Immunol; 2002 Aug 01; 169(3):1444-52. PubMed ID: 12133970 [Abstract] [Full Text] [Related]
15. Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes. Kraft JR, Vance RE, Pohl J, Martin AM, Raulet DH, Jensen PE. J Exp Med; 2000 Sep 04; 192(5):613-24. PubMed ID: 10974028 [Abstract] [Full Text] [Related]
16. Prostaglandin E2 induces the expression of functional inhibitory CD94/NKG2A receptors in human CD8+ T lymphocytes by a cAMP-dependent protein kinase A type I pathway. Zeddou M, Greimers R, de Valensart N, Nayjib B, Tasken K, Boniver J, Moutschen M, Rahmouni S. Biochem Pharmacol; 2005 Sep 01; 70(5):714-24. PubMed ID: 15978547 [Abstract] [Full Text] [Related]
17. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Mingari MC, Vitale C, Cantoni C, Bellomo R, Ponte M, Schiavetti F, Bertone S, Moretta A, Moretta L. Eur J Immunol; 1997 Jun 01; 27(6):1374-80. PubMed ID: 9209487 [Abstract] [Full Text] [Related]
18. Expression of Ly49E and CD94/NKG2 on fetal and adult NK cells. Van Beneden K, Stevenaert F, De Creus A, Debacker V, De Boever J, Plum J, Leclercq G. J Immunol; 2001 Apr 01; 166(7):4302-11. PubMed ID: 11254682 [Abstract] [Full Text] [Related]
19. Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells. Chattopadhyay S, O'Rourke J, Cone RE. Int Immunol; 2008 Apr 01; 20(4):509-16. PubMed ID: 18359787 [Abstract] [Full Text] [Related]
20. C-type lectin-like receptors in peptide-specific HLA class I-restricted cytotoxic T lymphocytes: differential expression and modulation of effector functions in clones sharing identical TCR structure and epitope specificity. Noppen C, Schaefer C, Zajac P, Schütz A, Kocher T, Kloth J, Heberer M, Colonna M, De Libero G, Spagnoli GC. Eur J Immunol; 1998 Apr 01; 28(4):1134-42. PubMed ID: 9565352 [Abstract] [Full Text] [Related] Page: [Next] [New Search]